◆英語タイトル:Osiris Therapeutics Inc - Strategic SWOT Analysis Review
◆商品コード:DATA8013726
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月21日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Osiris Therapeutics Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Osiris Therapeutics, Inc. (Osiris) is a regenerative medicine company involved in the research, development and marketing of regenerative medicine products. The company developed the world’s first approved stem cell drug. It offers products in wound care, orthopedics, and sports medicine market. Osiris develops products based on BioSmart, a proprietary process for tissue and cell preservation that maintains integrity of the biological materials. Osiris, Grafix, Stravix and Cartiform are trademarks of Osiris. The company continues to advance its research and development (R&D) in biotechnology by focusing on innovation in regenerative medicine including stem cell research, bioengineering and viable tissue based products. Osiris is headquartered in Columbia, Maryland, the US.
Osiris Therapeutics Inc Key Recent Developments
Oct 23,2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane
Oct 19,2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology
Jun 26,2017: Osiris Appoints Linda Palczuk to serve as its President & CEO
Jun 26,2017: Osiris Therapeutics appoints Linda Palczuk as president and CEO
May 31,2017: Osiris Appoints David White to its Board of Directors
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Osiris Therapeutics Inc – Key Facts 5
Osiris Therapeutics Inc – Key Employees 6
Osiris Therapeutics Inc – Key Employee Biographies 7
Osiris Therapeutics Inc – Major Products and Services 8
Osiris Therapeutics Inc – History 9
Osiris Therapeutics Inc – Locations And Subsidiaries 12
Head Office 12
Section 2 – Company Analysis 13
Osiris Therapeutics Inc – Business Description 13
Osiris Therapeutics Inc – Corporate Strategy 14
Osiris Therapeutics Inc – SWOT Analysis 15
SWOT Analysis – Overview 15
Osiris Therapeutics Inc – Strengths 15
Osiris Therapeutics Inc – Weaknesses 16
Osiris Therapeutics Inc – Opportunities 17
Osiris Therapeutics Inc – Threats 18
Osiris Therapeutics Inc – Key Competitors 19
Section 3 – Company’s Lifesciences Financial Deals and Alliances 20
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 22
Osiris Therapeutics Inc, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
Oct 23, 2017: Osiris Announces a Peer-Reviewed Publication of a Scientific Study Reporting Antimicrobial Properties of Human Cryopreserved Viable Amniotic Membrane 24
Oct 19, 2017: Osiris Therapeutics to Present 10 Advanced Clinical and Scientific Abstracts, Including an Exclusive Oral Presentation on its New Ambient Viable Tissue Preservation Technology 25
Jun 26, 2017: Osiris Appoints Linda Palczuk to serve as its President & CEO 26
May 31, 2017: Osiris Appoints David White to its Board of Directors 27
Apr 13, 2017: Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal 28
Apr 13, 2017: Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal 29
Apr 04, 2017: Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology 30
Mar 31, 2017: Osiris Therapeutics Announces Change in its Board of Directors 32
Mar 30, 2017: Osiris Therapeutics Launches Prestige Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues 33
Mar 27, 2017: Osiris Therapeutics Completes Restatement of 2014 Financial Statements 34
Section 5 – Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35
List of Tables
Osiris Therapeutics Inc, Key Facts 5
Osiris Therapeutics Inc, Key Employees 6
Osiris Therapeutics Inc, Key Employee Biographies 7
Osiris Therapeutics Inc, Major Products and Services 8
Osiris Therapeutics Inc, History 9
Osiris Therapeutics Inc, Key Competitors 19
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 20
Osiris Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 22
Osiris Therapeutics Inc, Recent Deals Summary 23